Get started
Author

Richard Charles G Pollok

Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
2022 · Brittney S Sheena, Lindsey Hiebert, et al. · ˜The œLancet. Gastroenterology & hepatology · 808
PDF
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
2022 · Rajesh Sharma, Mohsen Abbasi-Kangevari, et al. · ˜The œLancet. Gastroenterology & hepatology · 650
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
2023 · William M Gardner, Christian Razo, et al. · The Lancet Haematology · 636
PDF
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019
2022 · Giulio Castelpietra, Ann Kristin Skrindo Knudsen, et al. · The Lancet Regional Health - Europe · 346
PDF
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
2021 · Natalie C Galles, Patrick Y Liu, et al. · The Lancet · 215
PDF
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019
2021 · Deepa Jahagirdar, Magdalene K Walters, et al. · The Lancet HIV · 130
PDF
Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
2024 · Hannah Han, Ian D Letourneau, et al. · ˜The œLancet. Gastroenterology & hepatology · 90
PDF
Prevalence and Duration of Gastrointestinal Symptoms Before Diagnosis of Inflammatory Bowel Disease and Predictors of Timely Specialist Review: A Population-Based Study
2020 · J Blackwell, S Saxena, et al. · Journal of Crohn s and Colitis · 64
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
2022 · Laurent Peyrin-Biroulet, Laurent Peyrin-Biroulet, et al. · Clinical Gastroenterology and Hepatology · 39
PDF
DOP59 What is the relationship between fatigue, pain and urgency in people with inflammatory bowel disease? Results of the IBD-BOOST survey in 8486 participants
2023 · A Hart, L Miller, et al. · Journal of Crohn s and Colitis · 4
PDF
Clinical utility of pre-treatment four-digit-resolution HLA genotyping to guide anti-tumor necrosis factor choice and concomitant immunomodulator use
2025 · Phoebe Hodges, Christopher Roberts, et al. · Journal of Crohn s and Colitis · 3
P0832 Real-world effectiveness of risankizumab in Crohn’s Disease: The UK Experience
2025 · A Elford, N Plevris, et al. · Journal of Crohn s and Colitis · 3
PMO-6 Impact of consultation frequency and time to diagnosis on subsequent Inflammatory Bowel Disease outcomes
2021 · Nishani Jayasooriya, S Saxena, et al. · 3
PDF
DOP85 Rising depression and antidepressant use amongst inflammatory bowel disease patients
2019 · J Blackwell, S Saxena, et al. · Journal of Crohn s and Colitis · 2
PDF
Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
2026 · Nurulamin M Noor, Mohmmed Tauseef Sharip, et al. · ˜The œLancet. Gastroenterology & hepatology · 1
Prevalence and factors associated with obesity in patients with inflammatory bowel disease (IBD) treated with infliximab and vedolizumab across the UK
2026 · Christopher Roberts, Phoebe Hodges, et al. · Frontline Gastroenterology · 1
982 Randomised Controlled Trial of Withdrawal of Thiopurines When Switching From Intravenous to Subcutaneous Infliximab: Results of the Minimise Study
2026 · Peter M. Irving, Andrea Centritto, et al. · Gastroenterology · 1
Real-world effectiveness of risankizumab in Crohn’s disease: a pan UK retrospective cohort study
2026 · Alexander Thomas Elford, Nathan Constantine-Cooke, et al. · Frontline Gastroenterology · 1
PDF
PWE-117 Have Perianal Surgery Rates Decreased With The Rise In Thiopurine Use In Crohn’s Disease?
2014 · V Chhaya, S Saxena, et al. · Gut · 1
PDF
Clinical and Psychosocial Burden of Inflammatory Bowel Disease Among Transgender Individuals: A National BioResource Cohort Study
2026 · Michael Colwill, Richard Pollok, et al. · Clinical and Experimental Gastroenterology
PDF
Clinical and Psychosocial Burden of Inflammatory Bowel Disease Among Transgender Individuals: A National BioResource Cohort Study
2026 · Colwill M, Pollok R, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
O62 Randomised controlled trial of withdrawal of thiopurines when switching from intravenous to subcutaneous infliximab: results of the MINIMISE study
2026 · Peter Irving, Andrea Centritto, et al.
PDF
P240 Gender identity and inflammatory bowel disease: a retrospective bioresource cohort study
2026 · Michael Colwill, Chandni Radia, et al. · E-Posters
Resolving inflammatory bowel disease risk variants to genes and cell types
2026 · Laura Fachal, Rui Zhang, et al. · medRxiv
PDF
Exome sequencing directly implicates 68 genes in inflammatory bowel disease
2026 · Ruifei Zhu, Qian Zhang, et al. · medRxiv
Works count: 49
Citation count: 2,995
H-index: 9
I10-index: 9
Year
Topic
Type